N. Taniguchi

发表

A Role of Androgen Receptor Protein in Cell Growth of an Androgen-Independent Prostate Cancer Cell Line

S. Kato, E. Suzuki, K. Takeyama, 2005, Bioscience, biotechnology, and biochemistry.

Binding and Signal Transduction Characteristics of the Nonpeptide Vasopressin V1A Receptor-Selective Antagonist YM218 in Cultured Rat Mesangial Cells

K. Momose, M. Shibasaki, J. Tsukada, 2006, Pharmacology.

Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.

M. Shibasaki, J. Tsukada, W. Uchida, 2005, Vascular pharmacology.

Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.

M. Shibasaki, J. Tsukada, W. Uchida, 2005, Pharmacological research.

Effects of YM471, a nonpeptide AVP V1A and V2 receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells

J. Tsukada, W. Uchida, A. Tanaka, 2001, British journal of pharmacology.

Pharmacological characterization of YM471, a novel potent vasopressin V(1A) and V(2) receptor antagonist.

J. Tsukada, W. Uchida, A. Tanaka, 2002, European journal of pharmacology.

Effect of YM471, an orally active non-peptide arginine vasopressin receptor antagonist, on human vascular smooth muscle cells

J. Tsukada, W. Uchida, A. Tanaka, 2002, Journal of hypertension.

Toward the synthesis of phomoidride D.

Aaron A. Bedermann, Graham K. Murphy, Barry M. Twenter, 2013, The Journal of organic chemistry.

Alterations of Renal Vasopressin V1A and V2 Receptors in Spontaneously Hypertensive Rats

J. Tsukada, W. Uchida, A. Tanaka, 2003, Pharmacology.

Total Synthesis of (±)-Phomoidride D.

Aaron A. Bedermann, Joyce C. Leung, Graham K. Murphy, 2018, Angewandte Chemie.

Stereoselective alkylation of dianions derived from chiral half-esters of monosubstituted malonic acids: asymmetric synthesis of α-alkyl α-amino acids and key synthetic intermediates for Hunteria and Aspidosperma indole alkaloids

M. Ihara, K. Fukumoto, N. Taniguchi, 1991 .

Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists.

M. Okada, T. Furutani, H. Koutoku, 2004, Chemical & pharmaceutical bulletin.

Enantioselective synthesis of monofluorinated chiral building blocks from malonic acid

M. Ihara, K. Fukumoto, N. Taniguchi, 1990 .

Enantioselective construction of quaternary stereogenic centres possessing a fluorine atom

M. Ihara, K. Fukumoto, N. Taniguchi, 1992 .

Highly potent and orally active non-peptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-y l)carbonyl]-2-phenylbenzanilide derivatives.

A. Tanaka, Y. Shimada, T. Yatsu, 2000, Chemical & pharmaceutical bulletin.

Asymmetric total synthesis of(–)-protoemetinol,(–)-protoemetine,(–)-emetine, and (–)-tubulosine by highly stereocontrolled radical cyclisations

M. Ihara, K. Fukumoto, N. Taniguchi, 1990 .

Enantioselective Synthesis of Monofluorinated Chiral Building Blocks from Malonic Acid.

M. Ihara, K. Fukumoto, N. Taniguchi, 1990 .

Enantioselective construction of a quaternary asymmetric carbon center: a versatile synthesis of .alpha.-alkyl .alpha.-amino acids

M. Ihara, K. Fukumoto, N. Taniguchi, 1989 .

Synthesis of polycyclic cyclobutane derivatives by tandem intramolecular Michael-aldol reaction under two complementary conditions: TBDMSOTf-Et3N and TMSI-(TMS)2NH

T. Taniguchi, M. Ihara, C. Kabuto, 1993 .

Novel construction of polycyclic systems fused to cyclobutane by tandem intramolecular Michael-Aldol reaction

M. Ihara, K. Fukumoto, N. Taniguchi, 1992 .

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl) benzanilide derivatives.

H. Koshio, A. Tanaka, T. Yatsu, 1997, Chemical & pharmaceutical bulletin.

Stereoselective construction of cis-transoid-cis-tricyclo[7.3.0.0]dodecanes by an intramolecular Diels–Alder reaction: a formal total synthesis of (±)-Δ9(12)-capnellene

Takayuki Suzuki, M. Ihara, K. Fukumoto, 1992 .

A stereoselective total synthesis of (±)-Δ9(12)-capnellene via the intramolecular Diels–Alder approach

Takayuki Suzuki, M. Ihara, K. Fukumoto, 1991 .

A Total Synthesis of (±)-Tacamonine (Pseudovincamone I) through Radical Cyclization

M. Ihara, K. Fukumoto, N. Taniguchi, 1994 .

A stereoselective total synthesis of (±)-dihydrocorynantheol via radical cyclisation

M. Ihara, T. Kametani, K. Fukumoto, 1987 .

N-Arylpiperazine-1-carboxamide derivatives: a novel series of orally active nonsteroidal androgen receptor antagonists.

M. Okada, E. Kawaminami, T. Furutani, 2005, Chemical & pharmaceutical bulletin.

THE SYNTHESIS OF 1BETA -FLUOROCARBAPENEM DERIVATIVE

M. Ihara, Y. Tokunaga, K. Fukumoto, 1996 .

Synthesis of chiral intermediates of quinine alkaloids and(+)-dihydroantirhine

M. Ihara, K. Fukumoto, N. Taniguchi, 1997 .

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de derivatives and 4'-(5,6-dihydro-4H-thiazolo[5,4-d][1]benzoazepine-6-carbonyl)benzanilid e derivatives.

H. Koshio, A. Tanaka, T. Yatsu, 2000, Chemical & pharmaceutical bulletin.

Effect of YM471, a nonpeptide AVP receptor antagonist, on human coronary artery smooth muscle cells

J. Tsukada, W. Uchida, A. Tanaka, 2002, Peptides.

A novel rearrangement of cyclobutanes to cyclopropanes; construction of tricyclo[5.4.0.0]undecane and bicyclo[4.1.0]heptane systems

T. Taniguchi, M. Ihara, K. Fukumoto, 1993 .

Asymmetric total synthesis of tacamonine (pseudovincamone I) via radical cyclization

M. Ihara, Y. Tokunaga, K. Fukumoto, 1994 .

Asymmetric syntheses of chiral propane-1,3-diols starting from malonic acid

M. Ihara, T. Kametani, K. Fukumoto, 1989 .

Sulfur-mediated intramolecular double Michael-type reaction: synthesis of trans-hydroindanes and mechanism

Shuichi Suzuki, M. Ihara, C. Kabuto, 1992 .

Sulfur‐Mediated Intramolecular Double Michael‐Type Reaction: Synthesis of trans‐Hydroindans and Mechanism.

M. Ihara, C. Kabuto, K. Fukumoto, 1993 .

Intramolecular Michael reaction using trialkylsilyl trifluoromethanesulfonates and tertiary amine system: total synthesis of (±)-ricciocarpin A

Shuichi Suzuki, K. Fukumoto, N. Taniguchi, 1993 .

Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target.

S. Kato, E. Suzuki, K. Takeyama, 2005, The Journal of pharmacology and experimental therapeutics.

Total synthesis of hydrocinchonidine and hydrocinchonine via photo-oxygenation of an indole derivative

M. Ihara, T. Kametani, K. Fukumoto, 1988 .

Homochiral syntheses of (–)-dihydrocorynantheol

M. Ihara, K. Fukumoto, N. Taniguchi, 1990 .

Homochiral Syntheses of (-)-Dihydrocorynantheol

M. Ihara, K. Fukumoto, N. Taniguchi, 1991 .

Highly enantiocontrolled total synthesis of (-)-protoemetinol

M. Ihara, T. Kametani, K. Fukumoto, 1988 .

Enantioselective synthesis of useful chiral precursors, unsymmetrical propane-1,3-diol derivatives, from malonic acid

M. Ihara, T. Kametani, K. Fukumoto, 1987 .

Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor.

M. Orita, J. Tsukada, A. Kakefuda, 2006, Bioorganic & medicinal chemistry.

Preparation of highly potent and selective non-peptide antagonists of the arginine vasopressin V1A receptor by introduction of a 2-ethyl-1H-1-imidazolyl group.

J. Tsukada, A. Tanaka, Y. Shimada, 2005, Chemical & pharmaceutical bulletin.

Preparation of non-peptide, highly potent and selective antagonists of arginine vasopressin V1A receptor by introduction of alkoxy groups.

A. Tanaka, Y. Shimada, A. Tahara, 2003, Chemical & pharmaceutical bulletin.

H. Koshio, A. Tanaka, T. Yatsu, 1997, Chemical & pharmaceutical bulletin.